Patient Performed Tissue Expansion for Two-stage Alloplastic Breast Reconstruction

Breast Reconstruction Clinical Trial

Official title: Patient Performed Tissue Expansion for Two-stage Alloplastic Breast Reconstruction

Status Not yet recruiting

Clinical Trial Summary

This study is designed to evaluate the feasibility and safety of patient performed tissue expansions in two-stage alloplastic breast reconstruction with tissue expanders. The investigators hypothesize that a motivated patient who learns and demonstrates proper technique can safely perform tissue expansions at home, with no increase in complications or problems with reconstruction. 30 participants will be recruited for this study, 10 into a Home Expansion Group, and 20 into a Control Group.

Clinical Trial Description

Two-stage tissue expander-to-implant reconstruction is the most common technique for breast reconstruction in the United States. Tissue expanders are used to increase the soft tissue envelope after mastectomy to provide adequate and healthy coverage of prosthetic breast implants. The current clinical standard of care entails an initial surgery for the placement of tissue expander device either in front or behind of the pectoralis muscle following a mastectomy. After an interval of a few weeks to allow surgical wound healing, the patient will make serial office visits (usually weekly) where the plastic surgeon or other clinical staff will inject the device with a bolus of saline. A probe is used to find the magnetic port embedded in the expander, which is then accessed with a sterile butterfly needle connected to a large syringe filled with saline. The serial injections continue until the tissue expander(s) have reached the desired size. The patient then undergoes a second surgery about 4-6 weeks after the last injection, to exchange the tissue expander with a breast implant. The tissue expansion process can be inconvenient for the patient, due to the time and cost associated with travel and coordination of frequent office visits. The office visits for tissue expander injections ultimately result with multiple additional encounters with a healthcare facility, which may be of concern to patients, in light of the COVID-19 pandemic. The saline tissue expander with internal filling port is still the clinical gold standard device for alloplastic breast reconstruction. But the safety, time benefits and healthcare utilization and cost savings of home inflation - as shown in studies using external filling port tissue expanders and carbon dioxide-filled tissue expanders - suggests that patient performed tissue expansions may also be feasible with conventional saline tissue expanders. This would obviate multiple outpatient visits usually required for saline injections. Eliminating the need for saline injection clinic visits would benefit both the clinician and patient/families by reducing financial and time burdens, and limit potential exposures to COVID-19. Study Design: Ten women age 18 or above who met the inclusion and exclusion criteria below will be recruited and enrolled in the study. Study participants will be recruited from the principal investigator's clinic. Surgical technique and timing for initiation of expansion and implant exchange will be performed according to the principal investigator's usual protocol with saline tissue expanders. At the first expansion clinic visit, the saline injection will be performed by clinic staff, as per usual protocol. Clinic staff will provide teaching on the saline injection technique during this visit. At the second and third clinic visit, the participant will perform the saline injection under supervision by clinic staff in the right breast, the left breast will be expanded by the clinic staff. Starting the fourth expansion, participants will perform expansion in right breast prior to their clinic visit and left breast will be expanded by clinic staff. Thus participants will still be seen in person on a regular basis as per usual clinical protocol. If after the second and third visit the participant is unable to demonstrate ability and comfort to perform expansions on her own after the third clinic visit, she will be excluded from the study. Participants will be provided instructional materials and all supplies necessary to perform expansions at home. After the tissue expanders have been fully expanded, the participant will proceed to undergo the principal investigator's usual protocol of exchange to breast implants. If at any time the participant has problem with home expansion or no longer wants to be part of the study, she can leave the study and receive all expansions in the clinic per usual protocol. Objectives: - 1. Evaluate overall treatment success in undergoing alloplastic breast reconstruction - 2. Evaluate profile and rate of complications in patients performing tissue expansions at home - 3. Compare treatment success and complication profile/rate of right (patient performed tissue expansion) and left (clinic performed tissue expansion) breast - 4. Compare treatment success and complication profile/rate of patients who perform some tissue expansions at home vs patients who have all tissue expansions performed by clinical staff - 5. Evaluate patient's satisfaction in experience of learning and performing expansions at home ;

Related Conditions & MeSH terms

• Breast Reconstruction
• Tissue Expansion

• NCT number: NCT04781907
• Study type: Interventional
• Source: University of Wisconsin, Madison
• Contact: Rosaline Zhang, MD
• Phone: 608-263-1367
• Email: rzhang@uwhealth.org
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 2024
• Completion date: June 2025